AVITA Medical RCEL
NASDAQ RCEL
$12.72 +0.71 (+5.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023)

Updated

AVITA Medical (RCEL) posted Amortization of Deferred Charges of $86,000 for Q4 2023, up 1.2% from $85,000 a year earlier and up 1.2% from the prior quarter.

Analysis

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023) Analysis & Trends

For FY2023, AVITA Medical's Amortization of Deferred Charges came in at $341,000, up 0.9% from FY2022.

  • In prior years, AVITA Medical's Amortization of Deferred Charges was $338,000 in FY2022 (+102.4%) and $167,000 in FY2021.
  • According to Business Quant data, Amortization of Deferred Charges for the three prior quarters was $85,000 (Q3 2023), $85,000 (Q2 2023) and $85,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 AVITA Medical 393.39 Mn 325.07 Mn 17.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 86,000.00
Sep 30, 2023 85,000.00
Jun 30, 2023 85,000.00
Mar 31, 2023 85,000.00
Dec 31, 2022 86,000.00
Mar 31, 2022 85,000.00
Sep 30, 2021 82,000.00
Mar 31, 2021 50,000.00
API Access

AVITA Medical Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RCEL&period=max&api_key=YOUR_API_KEY